Predair

   
Google
 
Web NewDrugInformation.com

Predair


Drug - Predair
The trade name of the product as shown on the labeling.

Dosage - SOLUTION/DROPS; OPHTHALMIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Prednisolone Sodium Phosphate
Multiple ingredients are in alphabetical order.

Strength - EQ 0.11% PHOSPHATE
The potency of the active ingredient(s), Prednisolone Sodium Phosphate. May repeat for multiple part products.

Applicant - PHARMAFAIR
The firm name holding legal responsibility for Predair. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 088415
The FDA assigned number to Predair. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Predair. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Feb 29, 1984
The date Predair was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Predair. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Predair is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pharmafair Inc
The full name of the firm holding legal responsibility for the new application of Predair.

Predair